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Abstract
The aim of this study was to analyse the multigenerational effects of para-nonylphenol (NP) and
resveratrol (RES) on the body weight, organ weight and reproductive fitness of outbred CD-1 mice.
The data indicate that in male mice, NP had an effect on the weight of selected reproductive organs
and the kidneys in the parental (P) generation males. Effects on selected reproductive organs, the
liver and kidneys in the F1-generation males were also seen. In females, effects of NP on body
weight and kidney weight were seen in the P generation, but no effects on any measured parameter
were seen in the F1 generation. RES had no effect on body weight but did have some effect on
selected male and female reproductive organs in the P generation. RES altered the spleen and liver
weights of P-generation males and the kidney weight of F1-generation males. Acrosomal integrity
(using a monoclonal antibody against intra-acrosomal sperm proteins) was assessed for both
generations of NP- and RES-treated mice. A significant reduction in acrosomal integrity was seen
in both generations of NP-treated, but not in RES-treated, mice. Fewer offspring were observed in
the second litter of the F2 generation of mice treated with NP; no similar effect was seen in RES-
treated mice. The litter sex ratio was not different from controls. Unlike RES, NP had a negative
effect on spermatogenesis and sperm quality with a resultant impact on in vivo fertility.
Background
In this study we selected p-nonylphenol (NP) as a repre-
sentative endocrine disruptor (ED). EDs are those hetero-
geneous substances entering the body from the external
environment that can interfere with the action of the en-
docrine system through diverse mechanisms, for example,
receptor-mediated enzyme inhibition [1]. These substanc-
es can influence endocrine balance during the early phas-
es of an animal's life [2].
para-Nonylphenol (4-nonylphenol) is used in the prepa-
ration of lubricating oil additives, plasticizers and surface
active agents. It has also been found in polyvinyl chloride
(PVC) used in the food processing and packaging indus-
tries. NP ranks among the alkyl phenols that are relatively
persistent and accumulate in the lipids of living organisms
[3].
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p-Nonylphenol has been examined in a number of ani-
mal, usually rat, studies, with different doses and experi-
mental protocols and also with different results. Lee [4]
reported that neonatal exposure of rats to NP (8 mg/kg/
day) by daily intraperitoneal injection had an effect on the
weight of the reproductive organs and delayed testes de-
scent. De Jager et al. [5] exposed adult male rats to 100
mg/kg of NP and found an effect, particularly on sperma-
togenesis. In a study of the fertility potential of male rats
after gestation and early postnatal life, NP toxicity (100
mg/kg, 250 mg/kg, 400 mg/kg) to both testis and epidi-
dymis was found [6,7]. However, Odum and Ashby [8]
did not confirm an effect of NP (8 mg/kg/day) on the re-
productive tract.
As the findings of earlier papers were inconsistent, and in
some cases contradictory, we decided to use oubred mice
as another biomodel for analyzing low-dose NP effect.
Doses of 50 and 500 µg/l in drinking water were selected
and used in a multigenerational study.
Resveratrol (3,5,4'-trihydroxystilbene) – (RES) is a phyto-
alexin found in more than 300 edible plants and is a com-
ponent of the human diet. For example, it is present in
substantial amounts in red wine (4–20 mg/L) [9–12]. Res-
veratrol has a wide spectrum of biological activities, one
of them being oestrogenicity. The reported data are based
on the results of in vitro studies in the MCF-7 (estrogen-
positive) cell line [13]. Ashby et al. [14] did not show the
oestrogenic activity of RES in a uterotrophic assay. Few
data are available on the in vivo effect of RES. A dose of 3
mg/l in drinking water was selected based on the data re-
ported in a previous paper [11].
The objective of this study was to compare the effect of
two different substances (NP, RES) on body and organ
weights, the histological picture of the testes and ovaries,
the acrosomal integrity of the spermatozoa and the litter
size.
Materials and methods
Animals and treatments
CD1 (ICR) outbred mice (An Lab Ltd., Prague, Czech Re-
public) with heterozygosity and average number of pups
12–13 per litter were used for the experiments. The mice
(six control pairs without treatment and six pairs in each
experimental group) were kept under standardized condi-
tions at the Institute of Molecular Genetics, Prague, with
constant temperature and moisture and with a 12-h light
regime without stress factors. Food (ST1, Velas a.s., Lysa
nad Labem, Czech Republic) and water were available ad
libitum.
p-Nonylphenol (4-Nonylphenol; empirical formula,
C15H24O; mw 220.36; Sigma, Prague, Czech Republic;
Fig. 1A) was selected as a xenoestrogen and used at two
concentrations: 50 µg/l in drinking water and 500 µg/l in
drinking water. Resveratrol (3,5,4'-trihydroxystilbene;
empirical formula, C14H12O3; mw 228.2; Sigma, Prague,
Czech Republic; Fig. 1B) was selected as a phytoestrogen.
One concentration of RES was employed, 3 mg/l in drink-
ing water. Both drugs were administered in drinking water
for easier determination of the precise amount of the in-
gested drug. Adult mice two months old (parental or P-
generation) were exposed to the tested drugs for four
weeks, and then the animals were mated. The F1 genera-
tion was exposed to NP and RES during gestation, lacta-
tion, the prepubertal period and the pubertal period, up
to adulthood.
Body and organ weights
The control and experimental groups of the same sex were
killed at the same time. The males were killed at 100 days
of age and females at 130 days, and the reproductive or-
gans (testes, epididymides, prostate and seminal vesicles
in males and ovaries in females) and other organs (kid-
neys, liver and spleen) were dissected out and weighed in-
dividually. Relative organ weight was calculated as the
ratio between organ weight and body weight.
Preparation of tissues and histological examination
The right testis or right ovary were fixed in 10% neutral
formalin, embedded in paraffin, sectioned at 5 µm and
stained with hematoxylin-eosin. Leica DM XRA photomi-
croscope and Leica DC 100 camera were used for micro-
photography of histological sections. Image analysis
software (Leica) was used for histology evaluation (18
semiferous tubule parameters from all groups). Adobe
Photoshop 6.0 was used for final processing.
Preparation of cells
The spermatozoa of the cauda epididymis were obtained
from mice killed by cervical dislocation. Spermatozoa
were washed twice with phosphate-buffered saline (PBS),
Figure 1
A: The structure of p-nonylphenol (NP). B: The structure of 
resveratrol (RES).
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pH 7.4, centrifuged for 30 min at 200 g and then used in
experiments.
Acrosomal status tested by monoclonal antibody
Aliquots of a sperm suspension were smeared onto glass
slides. The smears were dried and fixed with acetone at
room temperature for 10 min, then rinsed with PBS and
incubated for 45 min at 37°C with a monoclonal anti-
body against intra-acrosomal proteins, Hs-14 (prepared
in our laboratory) [15], and used for determining the
acrosomal integrity of the spermatozoa. The antibody was
diluted in PBS to an immunoglobulin concentration of 20
µg/ml. After thorough washing with PBS, the smears were
incubated with FITC-conjugated swine anti-mouse immu-
noglobulins (SEVAC, Prague, Czech Republic), diluted
1:20 in PBS, for 45 min at 37°C, washed with PBS and
water, and mounted in Vectashield H-1200 + DAPI (Vec-
tor Laboratories, Inc., Burlingame, CA). For negative con-
trols, smears were incubated with a non-specific
monoclonal antibody, with the supernatant from cul-
tured myeloma cells, and with the FITC-conjugated sec-
ondary antibody only. Samples (200 sperm cells) from
each male were evaluated and viewed with a Nikon Labo-
phot-2 fluorescent microscope equipped with 40 × Nikon
Plan 40/0.65 lenses. Selected fields were chosen for pho-
tography with a COHU4 CCD camera (Inc. Electronics
Division, San Diego, USA) with the aid of LUCIA imaging
software (Laboratory Imaging, Ltd., Prague, Czech
Republic).
Statistical analysis
The statistical differences among compared groups were
analysed by one-way ANOVA and the Student-Newman-
Keuls test. P value < 0.01, (<0.05 respectively) was consid-
ered significant.
Results
Effect of p-nonylphenol on body weight, organ weight and 
in vivo fertility
NP had no effect on body weight in the males of the P gen-
eration, but there was a significant difference at the higher
dose (500 µg NP) in the F1 generation, compared to con-
trols (Table 1). NP (50 µg) had an effect on some repro-
ductive male organs; it decreased the absolute and relative
(ratio of tested organ weight to body weight) testes weight
in the P generation and decreased the absolute testes
weight in the F1 generation. Fifty µg NP also decreased the
absolute and relative prostate weight as compared to con-
trols in the F1 generation. The higher NP dose (500 µg) in-
creased the seminal vesicle weight in the F1 generation
(Table 1). NP also had effect on other body organs. The
lower dose statistically decreased the absolute kidney
weight in the P generation and the relative liver weight in
the F1 generation. Both doses statistically increased the
absolute kidney weight in the F1 generation. The higher
dose decreased the relative liver weight in the F1 genera-
tion (Table 1).
In females, the lower dose decreased body weight as com-
pared to controls in the P generation but had no effect on
body weight in the F1 generation. Both doses decreased
the relative kidney weight compared to controls in the P
generation (Table 2).
NP was tested for its potential reproductive toxicity in a
two-generational model in CD1 mice. The average litter
size (number of pups born) in two successive generations
Table 1: Effect of p-nonylphenol (NP; 50 µg and 500 µg) and resveratrol (RES; 3 mg) on different body parameters in male outbred CD1 
mice. The control and experimental groups of the same sex were killed at identical times. The body weights and organ weights were 
taken individually. The ratio between the organ weight and body weight represents the relative organ weight. (* P < 0.05, ** P < 0.01).
PF 1
Variable Control NP 50 NP 500 RES Control NP 50 NP 500 RES
Body weight (g) 39.42 ± 1.60 40.26 ± 0.52 42.83 ± 1.80 36.05 ± 2.52 36.88 ± 0.32 36.73 ± 0.95 42.32 ± 1.17** 36.65 ± 1.67
Testis weight (mg) 121.4 ± 6.1 99.3 ± 6.2** 126.5 ± 3.3 118.7 ± 5.1 112.5 ± 2.2 102.5 ± 2.6** 107.4 ± 8.3 114.5 ± 6.8
Testis weight/Body weight 3.09 ± 0.09 2.46 ± 0.12** 2.97 ± 0.10 3.36 ± 0.21 3.05 ± 0.07 2.87 ± 0.11 2.53 ± 0.16* 3.11 ± 0.07
Epididymis weight (mg) 56.1 ± 1.0 58.3 ± 2.1 69.2 ± 2.0** 53.8 ± 3.0 53.4 ± 3.1 49.0 ± 0.9 58.2 ± 1.5 56.9 ± 7.2
Epididymis weight/Body weight 1.44 ± 0.09 1.45 ± 0.03 1.63 ± 0.07* 1.51 ± 0.06 1.45 ± 0.09 1.34 ± 0.04 1.33 ± 0.05 1.55 ± 0.04
Prostate weight (mg) 140.5 ± 15.5 126.7 ± 6.2 142.98 ± 16.3 125.6 ± 26.4 149.2 ± 7.8 130.5 ± 5.6** 150.4 ± 3.5 149.2 ± 13.5
Prostate weight/Body weight 3.58 ± 0.41 3.15 ± 0.15 3.38 ± 0.46 3.60 ± 0.66 4.05 ± 0.21 3.55 ± 0.11* 3.57 ± 0.08 4.07 ± 0.28
Seminal vesicle weight (mg) 193.1 ± 9.5 184.1 ± 6.8 205.6 ± 16.6 156.2 ± 14.3** 154.5 ± 0.3 142.3 ± 7.9 226.6 ± 15.3** 126.9 ± 12.3*
Sem.ves.weight/Body weight 4.93 ± 0.28 4.57 ± 0.18 4.67 ± 0.26 4.34 ± 0.16* 4.19 ± 0.03 3.86 ± 0.19 4.38 ± 0.44 3.47 ± 0.24
Liver weight (mg) 2580 ± 152 2816 ± 75 2805 ± 103 2048 ± 162* 2749 ± 30 2397 ± 35** 2656 ± 123 2500 ± 191
Liver weight/Body weight 65.45 ± 3.86 69.95 ± 1.86 65.49 ± 2.40 56.81 ± 4.49 74.54 ± 0.76 65.26 ± 0.95** 62.76 ± 2.91** 68.21 ± 5.21
Kidney weight (mg) 404.3 ± 15.0 354.9 ± 7.8* 415.7 ± 10.0 355.7 ± 39.3 355.8 ± 2.5 396.9 ± 13.1** 406.3 ± 5.4** 321.6 ± 59.3*
Kidney weight/Body weight 10.27 ± 0.33 8.83 ± 0.32** 9.52 ± 0.46 9.78 ± 0.52 9.65 ± 0.15 10.83 ± 0.48 9.65 ± 0.43 8.73 ± 0.21
Spleen weight (mg) 99.4 ± 3.6 101.6 ± 5.7 108.8 ± 6.7 82.2 ± 7.1* 105.3 ± 13.2 93.68 ± 5.7 110.6 ± 12.4 111.7 ± 12.7
Spleen weight/Body weight 2.53 ± 0.11 2.52 ± 0.13 2.54 ± 0.08 2.31 ± 0.21 2.86 ± 0.42 2.54 ± 0.11 2.60 ± 0.19 3.01 ± 0.28Reproductive Biology and Endocrinology 2003, 1 http://www.RBEj.com/content/1/1/30
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was compared to controls using two experimental groups
(exposed to 50 µg and 500µg) in each generation. In the
experimental groups, neither NP concentration had any
effect on the number of pups per litter in the first litter of
the F2 generation. In the second litter of the F2 genera-
tion, NP significantly decreased the number of pups per
litter to 9 and 8.9 compared to 14.8 in the control group
(P<0.01) see Fig. 2. The sex ratio (female/male) remained
unchanged (Fig. 3).
Effect of p-nonylphenol on acrosomal integrity
The state of the acrosomal integrity in the control and ex-
perimental groups over two generations was tested by
using the monoclonal antibody Hs-14. In the control
groups, about 90% of mouse sperm acrosomes were pos-
itively labelled (Figs. 4, 5a). Acrosomal damage was found
in the group treated with p-nonylphenol. In the P genera-
tion of animals treated with 50 µg or 500 µg NP, the acro-
somal staining decreased to 77% and 80%, respectively
(Fig. 4). Acrosomal damage was also found in the F1 gen-
eration of both experimental groups (50, 500 µg NP),
where 65% and 64% of acrosomes were labelled, respec-
tively (Fig. 5b).
Effect of resveratrol on body weight, organ weight and in 
vivo fertility
RES had no effect on body weight in either males or fe-
males in the P or F1 generation (Table 1, Table 2). RES de-
creased the absolute and relative seminal vesicle weight as
compared to controls in the P generation and the absolute
vesicle and kidney weight in the F1 generation (Table 1).
In females treated with RES, the absolute and relative ova-
ry weight was decreased compared to controls in the P
generation (Table 2).
Unlike p-nonylphenol, resveratrol at a dose of 3 mg had
no significant effect on litter size. (Fig. 2). The sex ratio (fe-
male/male) was also unchanged (Fig. 3).
Effect of resveratrol on acrosomal integrity assessed by the 
Hs-14 antibody
The state of the acrosomal integrity in the control and ex-
perimental groups over two generations was tested using
the monoclonal antibody Hs-14. RES had no effect on
sperm quality. The acrosomal staining was comparable in
the P and F1 generations (Fig. 4).
Effect of p-nonylphenol and resveratrol on the number of 
sperm from the cauda epididymis
The number of spermatozoa from the cauda epididymis
was comparable between the control and experimental
groups. The control group had 21 and 20 × 106 spermato-
zoa/ml in the P and in the F1 generations, respectively.
The NP-treated group (50 µg) had 20 × 106 spermatozoa/
ml in the P generation and 16 × 106 spermatozoa/ml in
the F1 generation; the higher dose (500 µg) also did not
significantly affect the number of sperm in the P genera-
tion (17 × 106 sperm/ml) or in the F1 generation (19 ×
106sperm/ml). After RES treatment, 19 × 106 spermato-
zoa/ml were found in both generations.
Effect of p-nonylphenol and resveratrol on spermatogene-
sis, evaluated by histological methods
Parental generation males treated with the lower dose of
NP had normal spermatogenesis when compared with
controls (Fig. 6A). No apparent histopathological changes
of the seminiferous tubules (STs) were found in animals
treated with the higher dose of NP either. On the other
hand, the testes of F1 males showed alterations in the STs.
There were two main changes linked with NP oestrogenic-
ity: the sloughing of germ cells and the appearance of
round cells in the lumen of the STs (Fig. 6B). The observed
Table 2: Effect of p-nonylphenol (NP; 50 µg and 500 µg) and resveratrol (RES; 3 mg) on different body parameters in female outbred 
CD1 mice. The control and experimental groups of the same sex were killed at identical times. The body weights and organ weights 
were taken individually. The ratio between the organ weight and body weight represents the relative organ weight. (* P < 0.05, ** P < 
0.01).
PF 1
Varible Control NP 50 NP 500 RES Control NP 50 NP 500 RES
Body weight (g) 37.34 ± 0.70 33.54 ± 0.47** 35.68 ± 0.62 35.05 ± 1.02 35.90 ± 1.84 33.94 ± 1.66 38.29 ± 0.90 35.72 ± 1.42
Ovary weight (mg) 13.60 ± 0.89 13.50 ± 0.60 12.91 ± 0.73 10.12 ± 0.57* 14.37 ± 0.68 13.84 ± 0.94 15.49 ± 0.85 13.89 ± 1.58
Ovary weight/Body weight 0.37 ± 0.03 0.40 ± 0.02 0.36 ± 0.02 0.29 ± 0.03* 0.40 ± 0.01 0.42 ± 0.03 0.40 ± 0.02 0.39 ± 0.05
Liver weight (mg) 2613 ± 752 2532 ± 691 2554 ± 35 2642 ± 83 2857 ± 143 2799 ± 162 2945 ± 907 2361 ± 127
Liver weight/Body weight 69.98 ± 20.14 75.49 ± 20.60 71.58 ± 0.98 77.59 ± 2.44 79.58 ± 3.98 82.47 ± 4.77 76.91 ± 23.53 66.10 ± 3.56
Kidney weight (mg) 292.7 ± 7.3 249.6 ± 4.5 250.4 ± 5.4 306.9 ± 10.3 291.8 ± 9.0 283.4 ± 9.3 287.1 ± 9.6 283.0 ± 21.0
Kidney weight/Body weight 7.80 ± 0.20 7.46 ± 0.20** 7.01 ± 0.06* 8.40 ± 0.54 8.17 ± 0.24 8.59 ± 0.24 7.44 ± 0.23 7.90 ± 0.36
Spleen weight (mg) 159.9 ± 14.2 139.2 ± 3.0 156.6 ± 9.1 134.4 ± 10.8 174.1 ± 18.6 163.0 ± 21.8 170.9 ± 4.2 149.1 ± 22.0
Spleen weight/Body weight 4.36 ± 0.33 4.10 ± 0.22 4.39 ± 0.25 3.76 ± 0.38 4.79 ± 0.29 4.85 ± 0.49 4.46 ± 0.09 4.20 ± 0.64Reproductive Biology and Endocrinology 2003, 1 http://www.RBEj.com/content/1/1/30
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premature release of germ cells into the lumen is a sign of
Sertoli cell damage caused by the NP treatment. Such
changes were seen in both treatment groups, in five out of
six evaluated animals. There was no dose-response de-
pendence; marked pathology was seen following the low-
er dose as well as the higher.
According to the Student-Newman-Keuls test the differ-
ence in mean seminiferous tubule diameter was not
statistically significant between the different groups in P
generation. The lower mean diameter was statistically sig-
nificant (NP (50 µg) p < 0,05; NP (500 µg) p < 0.01) in
both exposed groups F1 generation compared to the con-
trol group. The difference between control and the higher
NP dose groups was statistically significant in both gener-
ations in seminiferous epithelium thickness. There was no
statistically significant difference in lumen diameter be-
tween control and exposed groups (Tab.3). The general
decrease in seminiferous tubule size is obvious from Fig.
6C.
Resveratrol treatment did not induce any alteration of tes-
tes morphology in any evaluated animal.
Effect of p-nonylphenol and resveratrol on ovaries, evalu-
ated by histological methods
The histology of the ovaries of control and NP-treated
mice appeared similar; the only difference was in the av-
erage number of atretic follicles. The Student-Newman-
Keuls Test showed a statistically significant overall differ-
ence between control and the higher NP dose groups (p <
0.01), (data not showed). Resveratrol treatment did not
affect ovarian morphology in either generation.
Discussion
We tested the effect of p-nonylphenol, an environmental
toxicant with oestrogenic properties, on the body weight,
reproductive organ weight and histology, and in vivo fer-
tility of the CD1 outbred mouse strain. This strain of mice
simulates better than inbred strains the genetic
heterozygosity in the human population. NP had an effect
on selected reproductive organs in the P generation. The
Figure 2
The effect of NP and RES on litter size. The figure shows the number of offspring (in one litter) in the F1 generation and the 
first and second litters of the F2 generation. A statistically significant difference was found between the control group and the 
groups treated by 50 or 500 µg NP in the second litter of the F2 generation (* P < 0.01).
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damage to the reproductive organs increased in the F1
generation, when NP influenced the animals during gesta-
tion, lactation and the pubertal period. In the group treat-
ed by the lower dose of NP, the prostate weight was
decreased, and in the group treated by the higher dose, a
lower body weight was found. Parental generation males
treated with the lower dose of NP had normal sperma-
togenesis when compared with controls. No marked
histopathological changes of the seminiferous tubules
were found. Interestingly, we detected damage to the acro-
some in spermatozoa already in the P generation. The
acrosomal status (% of acrosome-intact cells) of sperma-
tozoa decreased (compared to control) in the P genera-
tion by about 14% (50 µg NP) or 10% (500 µg NP). A
marked decrease was observed in the F1 generation: 26%
(50 µg NP) and 26% (500 µg NP). Both NP doses had a
similar effect on acrosomal damage in the P and F1 gener-
ations. The data indicate that we did not find any dose-de-
pendence effect. Our previous study confirmed that
monoclonal antibodies against intra-acrosomal sperm
proteins are valuable and sensitive markers for the evalu-
ation of sperm quality [15–20]. A correlation between
sperm quality and fertility has been demonstrated using
animal and human pathological spermatozoa [18–22]
and also by our own results (prepared for publication).
We can conclude that although spermatogenesis was es-
tablished in the P generation, NP had an effect on sperm
quality. In contrast to the quality, the number of sperma-
tozoa was similar to the control group (in the P and F1
generations). Depending on duration of exposure, there
were progressive degenerative changes in the reproductive
organs. The damage to male reproductive organs and
gametes is evidently not crucial in the P generation, as
there was no effect on the number of pups born in the F1
generation. Finally, a statistically significant decrease in
the number of pups appeared in the second litter of the F2
generation. However, the sex ratio of live pups and the
number of live pups per litter did not differ among treat-
ment and control groups in the tested generation.
Unlike NP, RES had no damaging effect on spermatogen-
esis, sperm number or sperm quality. We did not find any
Figure 3
Males born in one litter (%) in the control group and in the experimental groups treated by NP and RES in the F1 generation 
and the first and second litters of the F2 generation. The sex ratios (female/male) did not differ.
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differences in the morphology of the ovaries. We conclude
that phytoestrogen RES had no effect on in vivo fertility in
our experimental system.
We have compared the results presented here with those
of our previous paper [15], in which we tested two rather
low doses of bisphenol-A. The lower dose of BPA had a
stronger effect on all tested parameters than the higher
dose of BPA. Bisphenol-A had an effect on spermatogene-
sis in the males of the experimental groups, where infertile
males without spermatozoa were found. The lower dose
of BPA also significantly decreased the number of pups in
the F1 and F2 generations in comparison with the control
group. Unlike BPA, NP treatment in our study had a sim-
ilar effect at both concentration used. Neither NP dose
had any effect on the number of spermatozoa in the cauda
epidididymis. Contrary to our results with BPA, NP had a
comparable toxic effect on the quality of spermatozoa at
both doses in the P and F1 generations, but the effect on
in vivo fertility manifested itself later, in the second litter
of the F2 generation, when the number of pups was signif-
icantly decreased.
On the other hand, resveratrol treatment showed no ad-
verse effect both on sperm quality and fertility. Histology
of reproductive organs of both sexes did not indicate any
sign of damage.
A deleterious effect of NP treatment appeared following
long-term treatment with low NP doses. This observation
is alarming, considering the persistence of harmful NP
products in the environment.
The data presented here add to the biological information
available for the study of testicular dysgenesis syndrome,
with underlying entities such as poor semen quality, tes-
ticular cancer, undescended testes and hypospadias,
which may be increasing because of adverse environmen-
tal influences [23].
Figure 4
The effect of NP and RES on acrosomal integrity. Acrosomal integrity was evaluated as the number of spermatozoa with a 
labelled acrosome using a monoclonal antibody against intra-acrosomal proteins (Hs-14). Two hundred cells were evaluated in 
each group. A statistically significant difference was found between the control group and the experimental groups treated with 
50 or 500 µg NP in the first and second generations (* P < 0.01).
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Figure 5
Immunofluorescent visualization of acrosomes (green) with a monoclonal antibody against intra-acrosomal proteins (Hs-14). A: 
Most spermatozoa (90%) were labelled in the control group. B: The loss of proteins from the acrosome of spermatozoa 
(arrow) in the F1 generation after 500 µg NP treatment. Blue – nucleus labelled by DAPI. Scale bars = 20 µm.Reproductive Biology and Endocrinology 2003, 1 http://www.RBEj.com/content/1/1/30
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The results provide much-needed information for detect-
ing other symptoms in the study of reproductive prob-
lems. Our results also confirm the usefulness of
monoclonal antibodies directed against intra-acrosomal
proteins as markers detecting sperm damage.
Acknowledgments
This work was supported by the grants Nos. 303/00/1651, 204/02/1373 and 
525/99/1338 from the Grant Agency of the Czech Republic and grant No. 
NJ 5851-3 from the Grant Agency of the Ministry of Health of the Czech 
Republic.
References
1. Mantovani A Xenobiotics with potential endocrine activities
("endocrine disruptors"): an emerging public health
problem 2002, [http://www.endodisru.iss.it] 
2. Mantovani A Definizione di limiti massimi di residui negli ali-
menti: criteri per assicurare una adeguata protezione nei
confronti dellínfazia Notiziario dellÍnstituto Superiore di Sanita 1999,
12:5-8
3. Ahel M, McEvoy J and Giger W Bioaccumulation of the lipophilic
metabolites of nonionic surfactants in freshwater organisms
Environ Pollut 1993, 79:243-248
4. Lee PC Disruption of male reproductive tract development
by administration of the xenoestrogen, nonylphenol, to male
newborn rats Endocrine 1998, 9:105-111
5. De Jager C, Bornman MS, Wandrag S and van der Horst G I. Effect
of p-nonylphenol, an environmental toxicant with oestro-
genic properties, on fertility potentiall in adult male rats An-
drologia 1999, 31:99-106
6. De Jager C, Bornman MS and Oosthuizen MC II. The effect of p-
nonylphenol on the fertility potential of male rats after ges-
tational, lactational and direct exposure  Andrologia 1999,
31:107-113
7. De Jager C, Bornman MS, Wandrag S and Sharp VW The lethal
dose and potential reproductive effects of p-nonylphenol in
rats: a preliminary study Arch Androl 2001, 46:183-187
8. Odum J and Ashby J Neonatal exposure of male rats to nonyl-
phenol has no effect on the reproductive tract Toxicol Science
2000, 56:400-404
9. Landcake P and Price RJ The production of resveratrol by Vitis
vinifera and other members of the Vitacea as a response to
infection or injury Physiol Plant Pathol 1976, 9:77-86
Figure 6
Light photomicrographs of testes. A: Normal spermatogenesis and a normal arrangement of late spermatids were found in the 
control group. B: NP 50 µg treated group, F1 generation. Sloughing of germinal cells (arrows) and the appearance of round 
cells in seminiferous tubules (ST) (see insert, detail of ST) were found in the testes of both NP-treated groups. Note ST tubule 
without germ cells (arrowhead). C: NP 500 µg treated group, F1 generation. The decrease in STs diameter is obvious. Haema-
toxylin-eosin stain. Scale bars = 100 µm.
Table 3: Effect of p-nonylphenol (NP; 50 µg and 500 µg) on different semiferous tubule parameters in male outbred CD1 mice. Student-
Newman-Keuls Multiple RangeTest. (* P < 0.05, ** P < 0.01).
PF 1
Variable Control NP 50 NP 500 Control NP 50 NP 500
Seminiferous tubule diameter (µm) 144.96 ± 4.5 144.02 ± 6.5 128.11 ± 4.8 176.02 ± 5.9 158.5 ± 6.5* 147.03 ± 4.8**
Epithelium thickness (µm) 50.54 ± 1.8 49.0 ± 2.1 41.62 ± 2.3** 53.11 ± 1.5 46.93 ± 2.1* 40.43 ± 2.4**
Lumen diameter (µm) 51.59 ± 3.3 63.84 ± 4.8 55.53 ± 4.0 77.27 ± 2.5 80.80 ± 6.1 74.11 ± 3.6Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
Reproductive Biology and Endocrinology 2003, 1 http://www.RBEj.com/content/1/1/30
Page 10 of 10
(page number not for citation purposes)
10. Siemann GJ and Creasy LL Concentration of the phytoalexin
resveratrol in wine American Journal of Ecology and Viticulture 1992,
43:49-52
11. Melzoch K, Filip V, Buckiova D, Hanzlikova I and Smidrkal J Resver-
atrol – occurrence in wine originating from Czech vineyard
regions and effect on human health Czech J Food Sci 2000, 18:35-
40
12. Savouret JF and Quesne M Resveratrol and cancer: a review Bi-
omed Pharmacother 2002, 56:84-87
13. Gehm BD, McAndrews JM, Chien PY and Jameson JL Resveratrol, a
polyphenolic compound found in grapes and wine, is an ago-
nist for the estrogen receptor Proc Natl Acad Sci U S A 1997,
94:14138-14143
14. Ashby J, Tinwell H, Pennie W, Brooks AN, Lefevre PA, Beresford N
and Sumpter JP Partial and weak oestrogenicity of the red wine
constituent resverstrol: consideration of its superagonist ac-
tivity in MCF-7 cells and its suggested cardiovascular protec-
tive effect J Appl Toxicol 1999, 19:39-45
15. Peknicova J, Kyselova V, Buckiova D and Boubelik M Effect of an en-
docrine disruptor on mammalian fertility. Application of
monoclonal antibodies against sperm proteins as markers
for testing sperm damage Amer J Reprod Immunol 2002, 47:311-
318
16. Peknicova J and Moos J Monoclonal antibodies against boar
acrosomal antigens labeling undamaged acrosomes of
spermatozoa in immunofluorescence test  Andrologia 1990,
22:427-435
17. Peknicova J, Moos J, Mollova M, Srsen V and Capkova J Changes in
immunochemical localization of acrosomal and sperm pro-
teins in boar spermatozoa during capacitation and induced
acrosome reaction Anim Reprod Sci 1994, 35:255-271
18. Peknicova J, Capkova J, Geussova G, Ivanova M and Mollova M Mon-
oclonal antibodies to intra-acrosomal protein inhibit gamete
binding in vitro Theriogenology 2001, 56:211-223
19. Peknicova J and Moos J Antibody against 28 kDa intra-acrosom-
al sperm proteins as a tool for evaluation of acrosomal integ-
rity in bull spermatozoa Folia Biol (Praha) 1998, 44:93-96
20. Chladek D, Peknicova J, Capkova J, Geussova G, Tepla O and Madar
J Application of monoclonal antibodies against sperm pro-
teins to diagnostics of human pathology and for selection of
suitable method in assisted reproduction Czech Gynaecol 2000,
65:28-32
21. Sutovsky P, Terada Y and Schateen G Ubiquitin-based sperm as-
say for the diagnosis of the male factor infertility Hum Reprod
2001, 15:2610-2620
22. Ramalho-Santos J, Terada Y and Schatten G VAMP/synaptobrevin
as an acrosomal marker for human sperm Fertil Steril 2002,
77:159-161
23. Skakkebaek NE, Rajpert E, De Meyts and Main M Testicular dys-
genesis syndrome: an increasingly common developmental
disorder with environmental aspects  Human Reprod 2001,
16:972-978